Physiomics (GB:PYC) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Physiomics plc, a leader in mathematical modelling and biostatistics, has released its end-of-year results presentation on its website, showcasing its role in supporting drug development and personalized medicine. The company continues to leverage its cutting-edge Virtual Tumour technology, having influenced over 100 commercial projects with major clients like Merck KGaA and CRUK. Investors can access the latest insights into the company’s strategic direction and market position via the updated presentation.
For further insights into GB:PYC stock, check out TipRanks’ Stock Analysis page.
